Weihong Wen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Radical Prostatectomy

High Fat Diet Induced

Genome Wide Identification

Top Venues

Molecular medicine (Cambridge, Mass.)

Cancer research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Lunbiao Gan, Tong Lu, Yu Lu, Hongtao Song, Jiayu Zhang, Keying Zhang, Shiqi Lu, Xinjie Wu, Fengze Nie, Sijia Di, Donghui Han, Fa Yang, Weijun Qin, Weihong Wen
Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8 + T cell infiltration. Journal for immunotherapy of cancer 12 (9) (2024)
Hongtao Song, Tong Lu, Donghui Han, Jiayu Zhang, Lunbiao Gan, Chao Xu, Shaojie Liu, Peng Li, Keying Zhang, Zhihao Hu, Hongji Li, Yu Li, Xiaolong Zhao, Jingliang Zhang, Nianzeng Xing, Changhong Shi, Weihong Wen, Fa Yang, Weijun Qin
YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer. Cancer research (2024)
Yao Jiang, Weihong Wen, Fa Yang, Donghui Han, Wuhe Zhang, Weijun Qin
Prospect of Prostate Cancer Treatment: Armed CAR-T or Combination Therapy. Cancers 14 (4) (2022)
Shaojie Liu, Donghui Han, Chao Xu, Fa Yang, Yu Li, Keying Zhang, Xiaolong Zhao, Jiayu Zhang, Tong Lu, Shiqi Lu, Changhong Shi, Rui Zhang, An-Gang Yang, Aizhi Zhao, Weijun Qin, Bo Yang, Weihong Wen
Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts. Molecular medicine (Cambridge, Mass.) 28 (1) (2022)